{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UA-BP-GGP-00066",
      "entity_text" : "IgE",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0923" ],
      "Organ" : [ "uberon:UBERON:0000479" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "Omalizumab (anti-IgE) was reported to similarly result in a significant histologic response [XREF_BIBR] but to be unlikely to efficiently treat EGE patients with a serum IgE level> 700 kIU/L [XREF_BIBR].",
  "reading_complete" : "2020-08-08T19:02:04Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T18:54:25Z",
  "trigger" : "level",
  "evidence" : [ "IgE level" ],
  "pmc_id" : "5095570",
  "score" : 0
}